A detailed history of West Coast Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, West Coast Financial LLC holds 1,800 shares of ABBV stock, worth $315,684. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,800
Previous 1,807 0.39%
Holding current value
$315,684
Previous $309,000 14.89%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$163.84 - $199.33 $1,146 - $1,395
-7 Reduced 0.39%
1,800 $355,000
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $35,446 - $41,394
229 Added 14.51%
1,807 $309,000
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $22,374 - $25,494
140 Added 9.74%
1,578 $287,000
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $5,228 - $5,888
-38 Reduced 2.57%
1,438 $222,000
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $39,008 - $45,157
-292 Reduced 16.52%
1,476 $220,000
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $27,562 - $34,299
208 Added 13.33%
1,768 $238,000
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $164,132 - $189,022
-1,135 Reduced 42.12%
1,560 $248,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $40,109 - $48,102
290 Added 12.06%
2,695 $435,000
Q3 2022

Oct 31, 2022

SELL
$134.21 - $153.93 $12,213 - $14,007
-91 Reduced 3.65%
2,405 $323,000
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $2,470 - $3,126
23 Added 0.93%
2,496 $338,000
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $123,849 - $140,587
-1,164 Reduced 32.0%
2,473 $267,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $73,451 - $80,861
718 Added 24.6%
3,637 $394,000
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $3,461 - $4,672
-43 Reduced 1.45%
2,919 $313,000
Q2 2020

Jul 13, 2020

BUY
$73.37 - $98.18 $217,321 - $290,809
2,962 New
2,962 $291,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track West Coast Financial LLC Portfolio

Follow West Coast Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Coast Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Coast Financial LLC with notifications on news.